Skip to main content
Caplight Logo









Cradle

Cradle

Private
AmsterdamHealthcare & Life Scienceshttps://www.cradle.bio/

Last Round

Series B

Nov 26, 2024

Total Funding Raised

$102.4M

Company Overview

Cradle is a biotechnology company that develops an enterprise-grade AI software platform designed to accelerate protein engineering for pharmaceutical, industrial, and food-tech sectors.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

protein designgenerative AIantibody discoverydrug discoveryin silico drug designprotein engineeringlab-in-the-loopAI-powered biotechSaaS platformtherapeutic proteinbiotech softwareAI drug discoverycomputational biologyclosed-loop designprotein optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cradle Comparables

Compare Cradle with similar companies based on industry and business-model similarity.

Cradle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Levitate
83%
OpenProtein.AI
81%
abYcloud
78%

Cradle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 26, 2024
Series ANov 28, 2023
SeedNov 17, 2022

Key People

Founding team and executive leadership

Nancy Xu

Coach To CEO

Executive Team

Stef van Grieken

Co-Founder CEO

Founding Team

Daniel Danciu

CTO

Executive Team

Luba Protopopova

Chief Operating Officer

Executive Team

Cradle Investors

Notable investors and investment history

Cradle investors
InvestorRounds
Amino CollectiveSeed
Kindred CapitalSeed, Series A, Series B
Institutional Venture Partners (IVP)Series B
Index VenturesSeries B, Seed, Series A
Sir Nelson CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Marcus Schindler joins the Advisory Board, recruited by Occam Global.

  • Feb 24, 2026

    Added Argenx, a biotechnology company, as a customer.

Cradle Filings

Explore SEC and related filing metadata, where available.

Cradle filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cradle's valuation, stock price, and market status.

Is Cradle a public or private company?

Cradle is a private company.

What is the current stock price of Cradle?

Cradle is a private company with no public stock price. No recent secondary market data is available.

How much is Cradle worth (valuation)?

Valuation information for Cradle is not publicly available.

Can I buy Cradle stock?

Cradle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cradle's last funding round?

Cradle's most recent funding round was Series B on November 26, 2024.

Who are the main investors in Cradle?

Key investors in Cradle include Kindred Capital, Institutional Venture Partners (IVP), Index Ventures.

Will Cradle IPO soon?

No public IPO plans have been announced for Cradle.

How can I track Cradle secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cradle's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range92
Year Founded2021
Last FundingNov 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?